Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination

NCT00044668 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: AC2993

Sponsor

AstraZeneca

Collaborators

[object Object]